EP 1165092 A1 20020102 - CYCLOPENTANONE DERIVATIVES AND THEIR USE
Title (en)
CYCLOPENTANONE DERIVATIVES AND THEIR USE
Title (de)
CYCLOPENTANON-DERIVATE, UND IHRE THERAPEUTISCHE VERWENDUNG
Title (fr)
COMPOSES CHIMIQUES ET LEURS APPLICATIONS
Publication
Application
Priority
- GB 0001086 W 20000322
- GB 9906587 A 19990322
- US 12696899 P 19990330
Abstract (en)
[origin: WO0056341A1] 4- and 5-oxacyclopent-2-en-1-ones have significant activity in activating HSF and in inhibiting NF- kappa B. They are believed to be useful in treating a wide range of disorders including viral-mediated disorders, bacterial-mediated disorders, disorders mediated by radiation (e.g. by UV-radiation), inflammatory disorders, disorders of the immune system, ischemia, arteriosclerosis, disorders involving cell proliferation (e.g. cancers), disorders involving damage to, or killing of cells (e.g. oxidative cell damage) and diabetes.
IPC 1-7
IPC 8 full level
A23K 1/18 (2006.01); A23K 1/16 (2006.01); A61K 31/12 (2006.01); A61K 31/5575 (2006.01); A61K 31/695 (2006.01); A61P 3/10 (2006.01); A61P 3/14 (2006.01); A61P 9/10 (2006.01); A61P 29/00 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 39/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A23K 20/105 (2016.05); A23K 50/80 (2016.05); A61K 31/122 (2013.01); A61K 31/695 (2013.01)
Citation (search report)
See references of WO 0056341A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0056341 A1 20000928; AU 3665700 A 20001009; CA 2366877 A1 20000928; EP 1165092 A1 20020102; HK 1041200 A1 20020705; JP 2002539264 A 20021119; NZ 514522 A 20040326
DOCDB simple family (application)
GB 0001086 W 20000322; AU 3665700 A 20000322; CA 2366877 A 20000322; EP 00915293 A 20000322; HK 02100880 A 20020205; JP 2000606245 A 20000322; NZ 51452200 A 20000322